What are the main bacteria species involved in Small Intestine Bacterial Overgrowth (SIBO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Main Bacteria Species Involved in Small Intestinal Bacterial Overgrowth (SIBO)

The main bacteria species involved in SIBO include Streptococcus (71%), Escherichia coli (69%), and Lactobacillus (75%), along with other colonic and oropharyngeal bacteria that abnormally colonize the small intestine. 1

Bacterial Composition in SIBO

  • SIBO is characterized by an abnormally high bacterial population level in the upper gut, exceeding 10^5 organisms/ml (5 log colony-forming unit/ml) 1

  • The predominant microaerophilic bacteria found in SIBO include:

    • Streptococcus (71%; 6.4 log CFU/ml) 1
    • Escherichia coli (69%; 7.2 log CFU/ml) 1
    • Staphylococcus (25%; 6.2 log CFU/ml) 1
    • Klebsiella (20%; 7.1 log CFU/ml) 1
    • Proteus (11%; 6.1 log CFU/ml) 1
  • The predominant anaerobic bacteria found in SIBO include:

    • Lactobacillus (75%; 6.1 log CFU/ml) 1
    • Bacteroides (29%; 6.9 log CFU/ml) 1
    • Clostridium (25%; 5.5 log CFU/ml) 1
    • Veillonella (25%; 5.3 log CFU/ml) 1
    • Fusobacterium (13%; 4.8 log CFU/ml) 1
    • Peptostreptococcus (13%; 6.1 log CFU/ml) 1

Normal Small Intestinal Microbiota vs. SIBO

  • The normal small intestinal microbiota has considerably fewer bacteria compared to the colon, with a marked gradient from duodenum to distal ileum 2

  • In the normal small intestine, bacteria are typically Gram-positive aerobes proximally and Gram-negative and Gram-positive anaerobes and facultative anaerobes in the terminal ileum 2

  • In SIBO, there is a disruption of this normal pattern, with an average of 4.6 bacterial genera present in abnormal quantities 1

Methane-Producing Organisms in SIBO

  • When methane-producing organisms are predominant, the condition may be referred to as intestinal methanogen overgrowth (IMO), which is often associated with constipation rather than diarrhea 3

  • Methane-producing organisms are particularly difficult to eradicate and often require more aggressive treatment approaches 4

Pathophysiological Implications

  • The contaminating flora in SIBO includes commonly identified oropharyngeal and colonic flora, but at different levels from those usually found in their original locations 1

  • SIBO can significantly alter the intestinal microbiome, with a decrease in beneficial bacteria such as Bifidobacteria and Lactobacillus 5

  • In the small intestine, Streptococcus species play an important role in the rapid uptake and conversion of available simple carbohydrates 2

Clinical Significance

  • The bacterial overgrowth leads to symptoms such as bloating, abdominal pain, diarrhea, and malabsorption that significantly affect patients' quality of life 6

  • In methane-dominant SIBO, constipation is more common than diarrhea 3

  • SIBO can complicate up to 92% of cases of chronic pancreatitis with pancreatic exocrine insufficiency 2

Diagnostic Considerations

  • Jejunal aspirate culture showing >10^5 CFU/ml has traditionally been considered the gold standard for diagnosis, though this cutoff was established from samples following surgical diversion 2

  • Some studies suggest that a lower cutoff of >10^3 CFU/ml may be more appropriate for diagnosing SIBO in certain clinical contexts 2

  • Breath tests with detection of exhaled H2 are the most accessible diagnostic technique but require rigorous performance and interpretation 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.